In a report to the FDA, Merck says it has figured out how its blockbuster Type 2 diabetes drugs have become contaminated with nitrosamine. And the company has told the regulator that it can fix the ...
(Reuters) - Merck and Co's diabetes drug Januvia achieved the main goal of a long-awaited heart safety study, according to preliminary results released by the drugmaker on Monday, likely removing a ...
After years of battling over the patents on blockbuster diabetes drug Januvia, Merck and its generic rival Viatris are ready to put the case to rest. In a recent filing with the U.S. District Court ...
Januvia comes as a tablet that you swallow. Keep reading for details on Januvia and cost, and how to save money on prescriptions. Note: For more details on Januvia, see this in-depth article. The ...
The U.S. Food and Drug Administration said on Tuesday certain samples of sitagliptin, a compound in Merck's diabetes drug Januvia, were contaminated with a possible carcinogen. Aug 9 (Reuters) - The U ...
Merck stock has become dependent on its diabetes drug Januvia over the past couple of years for revenue growth. The franchise made up 12% of Merck's sales in the first quarter and probably a larger ...
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the primary results of the Trial Evaluating Cardiovascular Outcomes with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results